StockData

Enovis vs Globus Medical

ENOV and GMED side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ENOV and GMED compare

Globus Medical is the larger company, worth 6.0 times as much as Enovis ($9.4B against $1.6B).

Globus Medical grew revenue faster over the last twelve months (19.7% versus 4.9% for Enovis).

Globus Medical keeps more of each dollar of sales as profit, with a net margin of 17.0% compared with −48.0% at Enovis.

Globus Medical scores higher on the StockData Score (22 against 8 for Enovis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricENOVGMED
Size and price
Market cap$1.6B$9.4B
Share price$27.22$69.99
Change, 1 year−9.2%−17.1%
Change, 5 years−81.3%9.4%
Beta (5Y)0.080.73
Employees7,8026,000
StockData Score
Total score822 (better)
Valuation score46 (better)
Growth score25 (better)
Performance score05 (better)
Health score26 (better)
Dividend score00
Valuation
P/E–17.9×
P/S0.7× (better)3.0×
P/B1.1× (better)2.0×
EV/EBITDA9.2× (better)9.6×
P/FCF24.7×12.4× (better)
PEG–0.63
FCF yield4.1%8.0% (better)
Fair value$81.07$125.82
Margin of safety66.4% (better)44.4%
Growth
Revenue growth (TTM)4.9%19.7% (better)
Revenue growth, 5Y average14.9%30.1% (better)
Net income growth (TTM)–50.1%
EPS growth (TTM)–50.4%
EPS growth, 5Y average–31.2%
Profitability
Gross margin61.1%68.5% (better)
Operating margin−45.1%20.3% (better)
Net margin−48.0%17.0% (better)
FCF margin2.8%24.0% (better)
Return on equity−54.3%11.8% (better)
Return on invested capital−24.5%12.6% (better)
Financial health
Debt / equity0.87 (better)0.00
Net debt / EBITDA4.12–
Interest coverage−30.9×–
Current ratio1.984.62 (better)
Altman Z-score−0.249.56 (better)
Piotroski F-score49 (better)
Dividends and buybacks
Buyback yield–2.4%
Shareholder yield0.00%2.4% (better)
Ownership
Held by institutions122%88.9%
Held by insiders2.7%17.8%
Insider net buying, 12 months$842K (better)−$15.3M
Superinvestors holding11
Short interest, % of float18.8%8.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.